Cargando…
The oxidation and hypoglycaemic effect of sorafenib in streptozotocin-induced diabetic rats
BACKGROUND: Diabetes reduces the activity of CYP3A4 and may increase the exposure for the drugs metabolized by the isoenzyme. Sorafenib is a multi-targeted tyrosine kinase inhibitor (TKI), used for the treatment of advanced renal cell carcinoma, hepatocellular carcinoma and radioactive iodine resist...
Autores principales: | Karbownik, Agnieszka, Stachowiak, Anna, Urjasz, Hanna, Sobańska, Katarzyna, Szczecińska, Agnieszka, Grabowski, Tomasz, Stanisławiak-Rudowicz, Joanna, Wolc, Anna, Grześkowiak, Edmund, Szałek, Edyta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187206/ https://www.ncbi.nlm.nih.gov/pubmed/32016844 http://dx.doi.org/10.1007/s43440-019-00021-0 |
Ejemplares similares
-
Correction to: The oxidation and hypoglycaemic effect of sorafenib in streptozotocin-induced diabetic rats
por: Karbownik, Agnieszka, et al.
Publicado: (2021) -
In vivo assessment of the drug interaction between sorafenib and paracetamol in rats
por: Karbownik, Agnieszka, et al.
Publicado: (2020) -
The Influence of Paracetamol on the Penetration of Sorafenib and Sorafenib N-Oxide Through the Blood–Brain Barrier in Rats
por: Karbownik, Agnieszka, et al.
Publicado: (2020) -
Pharmacokinetic Drug Interaction Study of Sorafenib and Morphine in Rats
por: Karbownik, Agnieszka, et al.
Publicado: (2021) -
Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats
por: Karbownik, Agnieszka, et al.
Publicado: (2020)